Covered recipient · General Payments record
MUHAMMAD MUSSADAQ HUSSAIN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$8,701.42
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,573.51 | 51 |
| Education | $20.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $513.91 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $211.92 | 9 |
| Genentech USA, Inc. | $143.18 | 5 |
| Daiichi Sankyo Inc. | $85.16 | 3 |
| Celgene Corporation | $84.56 | 4 |
| Merck Sharp & Dohme Corporation | $82.10 | 3 |
| Gilead Sciences, Inc. | $70.69 | 3 |
| PFIZER INC. | $49.19 | 2 |
| PharmaEssentia USA Corporation | $45.06 | 2 |
| Incyte Corporation | $34.76 | 2 |
| Alexion Pharmaceuticals, Inc. | $34.38 | 1 |
| ABBVIE INC. | $29.38 | 1 |
| Adaptive Biotechnologies Corporation | $27.38 | 1 |
| Stemline Therapeutics Inc. | $23.40 | 1 |
| BeiGene USA, Inc. | $22.92 | 1 |
| Astellas Pharma US Inc | $22.70 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.83 | 1 |
| EMD Serono, Inc. | $20.65 | 1 |
| AVEO Pharmaceuticals, Inc. | $20.00 | 1 |
| EISAI INC. | $17.31 | 1 |
| GENZYME CORPORATION | $17.06 | 1 |
| Deciphera Pharmaceuticals Inc. | $16.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.